| 摘要 |
The invention relates to the use of rotigotine, its salts and prodrugs, as a medicament for preventing and/or treating Parkinson's plus syndrome, comprising administering to the patient the rotigotine, salts thereof or hydroxy phenol group derivatives thereof, said derivatives selected from an ether, ester, thiocarbonyl ester, carbamate, thiocarbamate, carbonate, acetal, ketal, acyloxy alkyl ether, oxythiocarbonyl ester, phosphate, phosphonate, sulfate, sulfonate or silylether. |
